J&J’s Dealmaker: Plenty of ‘Firepower,’ but Mostly Focused on Tuck-in M&A

The head of dealmaking at Johnson & Johnson said that biotech valuations have come back down to more reasonable levels that make it easier to get transactions done, although the company is mostly focused on tuck-ins rather than any huge acquisition. Nauman Shah, J&J’s global head for business development, spoke to Endpoints News at the Biotechnology Innovation Organization conference in San Diego this week. “Overall, valuations are generally reasonable,” Shah said, contrasting the pandemic period where biotech share prices surged and it was often hard for companies to find a middle ground on transactions.

Read the full article: J&J’s Dealmaker: Plenty of ‘Firepower,’ but Mostly Focused on Tuck-in M&A //

Source: https://endpts.com/jjs-dealmaker-plenty-of-firepower-but-mostly-focused-on-tuck-in-ma/

Scroll to Top